Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 12/5/2023China Biotech: Investors Fear a Negative Reaction from the US (FT)
  • 12/3/2023Navigating Another New Normal in China as De-risking Starts to Bite Pr...
  • 11/24/2023China Biopharma: Charting a Path to Value Creation (McKinsey)
  • 11/24/2023China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
  • 11/23/2023PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
  • 11/22/2023Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
  • 11/20/2023Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
  • 11/16/2023Riding The Tide, Realize the Future: The BD Paths For Chinese Biotech ...
  • 11/16/2023Chinese Patent Office Hands Down Key Ruling on Pharma Patent Requireme...
  • 11/15/2023China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Par...
  • 11/14/2023NMPA: Quick Review of 2022 Drug Review Annual Report
  • 11/10/2023China's Strength Is Innovation on Innovation, Western Partners Are Lin...
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/6/2023Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
  • 10/31/2023Big Questions Face MNC Pharma's China Business as Sustainability of th...
  • 10/31/2023Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
  • 10/29/20232023 Outlook for China's NRDL (Simon Kucher)
  • 10/26/2023Patent Linkage In China: What Do The First Decisions Tell Us About The...
  • 10/24/2023Infographic: Rare diseases in China (Research Partnership)
  • 10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/12/2023China's Vast Opportunities In Health Care Attract Global Telemedicine ...
  • 10/10/2023China Market Opportunities for International Pharmas (Lek)
  • 10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
  • 10/3/2023As Another New Normal of China Healthcare Dawns, Pharma MNCs Need to C...
  • 9/28/2023Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/26/2023Patent Linkage In China: What The First Decisions Reveal About The Dir...
  • 9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...
  • Page:5/7 Total number of articles:186: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group